Human medicines European public assessment report (EPAR): Alli (previously Orlistat GSK), orlistat, Date of authorisation: 22/07/2007, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Esperoct, turoctocog alfa pegol, Date of authorisation: 20/06/2019, Revision: 8, Status: Authorised

Clinical investigation of human normal immunoglobulin for subcutaneous and/or intramuscular administration (SCIg/IMIg) - Scientific guideline

EMA workshop on the challenges in drug development, regulation and clinical practice in hemoglobinopathies, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 July 2024, 14:00 (CEST) to 1 July 2024, 18:00 (CEST)

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties meeting with all eligible organisations - 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, 20 November 2024

Guidance for applicants seeking scientific support and advice on traditional herbal medicinal products

Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date of authorisation: 22/11/2024, Status: Authorised

Submission of Manufacturers, Manufacturing Business Operations (MBOs) and structured pack size data to Product Management Service (PMS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 10:00 (CET) to 25 November 2024, 11:30 (CET)

Three-year work plan for the Quality Drafting Group (QDG) of the Committee on Herbal Medicinal Products (HMPC)

Data protection notice for the Experts Management Tool and the handling of competing interests